News Northwest Biotherapeutics, Inc.

Equities

NWBO

US66737P6007

Delayed OTC Markets Other stock markets 09:31:13 2024-05-17 am EDT			5-day change	1st Jan Change
0.478 ^USD	-0.42%		-1.89%	-31.70%

May. 10	Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 21	Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Northwest Biotherapeutics: Q1 Earnings Snapshot	May. 10	AQ
Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 10	CI
Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors	Mar. 21	CI
Northwest Biotherapeutics, Inc. Announces Retirement of Jerry Jasinowski from the Board of Directors	Mar. 14	CI
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 05	CI
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification	Feb. 06	PR
Northwest Biotherapeutics announces that a Marketing Authorization Application has been submitted to the UK MHRA for DCVax-L for Glioblastoma	Dec. 22	AQ
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma	Dec. 21	PR
Northwest Biotherapeutics Announces Marketing Authorization Application Has Been Submitted to the UK MHRA for DCVax-L for Glioblastoma	Dec. 21	CI
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application	Nov. 22	PR
Northwest Biotherapeutics, Inc. announced that it has received $11.005 million in funding from Streeterville Capital, LLC	Nov. 09	CI
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Today's Top Nano-Cap Stock Watchlist (MGUY, AABB, NWBO, ICU)	23-10-19	AQ
Northwest Biotherapeutics Provides Update on Near Term Plans for Submission of Marketing Authorization Application	23-10-16	AQ
Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application	23-10-13	PR
Companies Spotlighted on "The Street Reports Podcast" Unveiling Secrets to Success: CLNV, HNRC, NWBO, ASRE	23-09-28	AQ
Penny Stock Momentum List (ATVK, ELTP, NWBO, ENZC)	23-09-25	AQ
Penny Stocks Set To Soar On News Watchlist (TBRIF, NWBO, IQST, TLOFF)	23-09-14	AQ
Today's OTC Momentum Watchlist (RGGI, DLOC, NWBO, HMBL)	23-09-13	AQ
Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board	23-09-12	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Northwest Biotherapeutics, Inc.

Equities

NWBO

US66737P6007

Summary

Filters